Skip to main content
Figure 3 | Respiratory Research

Figure 3

From: The laminin β1-competing peptide YIGSR induces a hypercontractile, hypoproliferative airway smooth muscle phenotype in an animal model of allergic asthma

Figure 3

YIGSR treatment increases allergen-induced eosinophilic inflammation in the submucosal airway compartment. (A) Ovalbumin-induced eosinophil numbers in the submucosal compartment are increased by YIGSR treatment. (B) YIGSR treatment does not affect eosinophilic cell number in the adventitial compartment. No effects of YIGSR were found in saline-challenged animals for any of the conditions. ***P < 0.001 compared to saline-treated, saline-challenged controls. #P < 0.05 compared to saline-treated, ovalbumin-challenged animals. Data represent means ± SEM of 5-7 animals.

Back to article page